Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma.
Jelinek T, Adamusova L, Popkova T, Tvrda I, Smejkalova J, Simicek M, Salounova D, Kascak M, Mihalyova J, Plonkova H, Duras J, Navratil M, Hajek R, Koristek Z. Jelinek T, et al. Among authors: smejkalova j. Bone Marrow Transplant. 2019 Jul;54(7):1107-1114. doi: 10.1038/s41409-018-0396-x. Epub 2018 Nov 20. Bone Marrow Transplant. 2019. PMID: 30459429
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.
Zátopková M, Ševčíková T, Fanfani V, Chyra Z, Říhová L, Bezděková R, Žihala D, Growková K, Filipová J, Černá L, Broskevičova L, Kryukov F, Minařík J, Smejkalová J, Maisnar V, Harvanová Ĺ, Pour L, Jungova A, Popková T, Bago JR, Anilkumar Sithara A, Hrdinka M, Jelínek T, Šimíček M, Stracquadanio G, Hájek R. Zátopková M, et al. Among authors: smejkalova j. Blood Adv. 2022 Jan 25;6(2):368-372. doi: 10.1182/bloodadvances.2020003876. Blood Adv. 2022. PMID: 34500459 Free PMC article. No abstract available.
Whole Exome Sequencing of Aberrant Plasma Cells in a Patient with Multiple Myeloma Minimal Residual Disease.
Zatopkova M, Filipová J, Jelínek T, Vojta P, Sevcikova T, Simicek M, Rihova L, Bezdekova R, Growkova K, Kufová Z, Smejkalová J, Hajdúch M, Pour L, Minárik J, Jungová A, Maisnar V, Kryukov F, Hájek R. Zatopkova M, et al. Among authors: smejkalova j. Klin Onkol. 2017 Summer;30(Supplementum2):75-80. doi: 10.14735/amko20172S75. Klin Onkol. 2017. PMID: 28903574 English.
[Comparison of standard prognostic factors with the deletion of 13q14 detected by interphase fluorescence in situ hybridization on separated and unseparated bone marrow cells in multiple myeloma].
Smejkalová J, Vranová V, Oltová A, Kuglík P, Filková H, Heinigová J, Kovárová L, Adam Z, Krejcí M, Pour L, Büchler T, Svobodník A, Vostrejsová S, Kalábová V, Vorlícek J, Penka M, Hájek R. Smejkalová J, et al. Cas Lek Cesk. 2005;144(7):483-8. Cas Lek Cesk. 2005. PMID: 16161543 Czech.
Quality of life of patients with psoriasis.
Šmejkalová J, Borská L, Hamáková K, Hodačová L, Čermáková E, Fiala Z. Šmejkalová J, et al. Cent Eur J Public Health. 2020 Sep;28(3):219-225. doi: 10.21101/cejph.a5611. Cent Eur J Public Health. 2020. PMID: 32997478 Free article.
59 results